Xing-rui Li
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment.
Journal: Oncogene
Published: December 08, 2025
AI-driven CRISPR screening: optimizing gene editing through automation and intelligent decision support.
Journal: Journal of translational medicine
Published: November 28, 2025
PKM2 phosphorylation by c-SRC activates glycolysis and metastasis with the stimulation of tumor-associated macrophages.
Journal: Cell communication and signaling : CCS
Published: July 31, 2025
TLScope: a deep learning framework for quantifying tertiary lymphoid structures from H&E images reveals prognostic heterogeneity across breast cancer subtypes.
Journal: Breast cancer research : BCR
Published: July 29, 2025
Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy.
Journal: Nature communications
Published: June 24, 2024
STT3-mediated aberrant N-glycosylation of CD24 inhibits paclitaxel sensitivity in triple-negative breast cancer.
Journal: Acta pharmacologica Sinica
Published: June 20, 2024
The role of lncRNA SNHG14 in gastric cancer: enhancing tumor cell proliferation and migration, and mechanisms of CDH2 expression.
Journal: Cell cycle (Georgetown, Tex.)
Published: January 09, 2024
A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients.
Journal: International immunopharmacology
Published: November 05, 2023
Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition.
Journal: Cancer letters
Published: November 02, 2023
Decoding the past and future of bone metastasis from breast cancer: A bibliometric analysis from 2003 to 2022.
Journal: Asian journal of surgery
Published: August 10, 2023
Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery.
Journal: BMC endocrine disorders
Published: January 19, 2023
Last Updated: 09/26/2026